F-star Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2021

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
F-star Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2021.
  • F-star Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$18.4M, a 70.6% decline year-over-year.
  • F-star Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$44.7M, a 0.4% decline year-over-year.
  • F-star Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$31.3M, a 22.1% decline from 2020.
  • F-star Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$25.6M, a 11.3% decline from 2019.
  • F-star Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$23M, a 0.7% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$31.3M -$5.66M -22.1% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 -$25.6M -$2.61M -11.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$23M -$159K -0.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$22.9M +$4.83M +17.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 -$27.7M -$10.3M -59.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-11
2016 -$17.4M -$5.8M -50.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-20
2015 -$11.6M Jan 1, 2015 Dec 31, 2015 10-K 2017-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.